Search for Clinical Trial Results
Churg-Strauss Syndrome - 25 Studies Found
Status | Study |
Not yet recruiting |
Study Name: Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study Condition: Asthma Date: 2016-10-17 Interventions: Drug: Reslizumab All subjects will receive Reslizumab |
Not yet recruiting |
Study Name: PRO Development for ANCA Associated Vasculitis Condition:
|
Completed |
Study Name: RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides Condition:
Interventions: |
Recruiting |
Study Name: Benralizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study Condition: Asthma Date: 2016-12-11 Interventions: Drug: Benralizumab one injection 30 mg under the subjects skin every 4 weeks for 8 weeks and then every |
Recruiting |
Study Name: Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides Condition:
Interventions: |
Completed |
Study Name: Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome Condition:
|
Completed |
Study Name: Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years Condition:
|
Completed |
Study Name: The ANCA Vasculitis Questionnaire (AAV-PRO©) Condition:
|
Completed |
Study Name: Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases Condition:
|
Recruiting |
Study Name: VCRC Tissue Repository Condition:
|